Gene · 3977
Papers2,592
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 2,592
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| MiRNA-29c-3p Promotes Intestinal Inflammation via Targeting Leukemia Inhibitory Factor in Ulcerative Colitis. | J Inflamm Res | 2021 | 34040415 | PubTator, text mining | PubMed |
| TCF-3-mediated transcription of lncRNA HNF1A-AS1 targeting oncostatin M expression inhibits epithelial-mesenchymal transition via TGFβ signaling in gastroenteropancreatic neuroendocrine neoplasms. | Aging (Albany NY) | 2021 | 34037532 | PubTator, text mining | PubMed |
| Integrated Single-Cell Atlas of Endothelial Cells of the Human Lung. | Circulation | 2021 | 34030460 | PubTator, text mining | PubMed |
| SOMAscan Proteomics Identifies Serum Biomarkers Associated With Liver Fibrosis in Patients With NASH. | Hepatol Commun | 2021 | 34027267 | PubTator, text mining | PubMed |
| Regulation of bone metastasis and metastasis suppressors by non-coding RNAs in breast cancer. | Biochimie | 2021 | 34019953 | PubTator, text mining | PubMed |
| Genomic features of rapid versus late relapse in triple negative breast cancer. | BMC Cancer | 2021 | 34006255 | PubTator, text mining | PubMed |
| Mouse Retinal Organoid Growth and Maintenance in Longer-Term Culture. | Front Cell Dev Biol | 2021 | 33996806 | PubTator, text mining | PubMed |
| Endocrine Pancreas Development and Dysfunction Through the Lens of Single-Cell RNA-Sequencing. | Front Cell Dev Biol | 2021 | 33996792 | PubTator, text mining | PubMed |
| Innovative Approaches in the Battle Against Cancer Recurrence: Novel Strategies to Combat Dormant Disseminated Tumor Cells. | Front Oncol | 2021 | 33987095 | PubTator, text mining | PubMed |
| Long non-coding RNA LINC00649 regulates YES-associated protein 1 (YAP1)/Hippo pathway to accelerate gastric cancer (GC) progression via sequestering miR-16-5p. | Bioengineered | 2021 | 33975517 | PubTator, text mining | PubMed |
| A scheme for inferring viral-host associations based on codon usage patterns identifies the most affected signaling pathways during COVID-19. | J Biomed Inform | 2021 | 33965637 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| CXCL1 Clone Evolution Induced by the HDAC Inhibitor Belinostat Might Be a Favorable Prognostic Indicator in Triple-Negative Breast Cancer. | Biomed Res Int | 2021 | 33959656 | PubTator, text mining | PubMed |
| Common Variants Associated With OSMR Expression Contribute to Carotid Plaque Vulnerability, but Not to Cardiovascular Disease in Humans. | Front Cardiovasc Med | 2021 | 33959646 | PubTator, text mining | PubMed |
| Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains. | Mol Cell | 2021 | 33957083 | PubTator, text mining | PubMed |
| Mutant KRAS Downregulates the Receptor for Leukemia Inhibitory Factor (LIF) to Enhance a Signature of Glycolysis in Pancreatic Cancer and Lung Cancer. | Mol Cancer Res | 2021 | 33931487 | PubTator, text mining | PubMed |
| Hypoxia Transcriptomic Modifications Induced by Proton Irradiation in U87 Glioblastoma Multiforme Cell Line. | J Pers Med | 2021 | 33923454 | PubTator, text mining | PubMed |
| Role of SHH in Patterning Human Pluripotent Cells towards Ventral Forebrain Fates. | Cells | 2021 | 33923415 | PubTator, text mining | PubMed |
| The Anticancer Effects of Flavonoids through miRNAs Modulations in Triple-Negative Breast Cancer. | Nutrients | 2021 | 33916931 | PubTator, text mining | PubMed |
| Detecting and Characterizing A-To-I microRNA Editing in Cancer. | Cancers (Basel) | 2021 | 33916692 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3977/papers?page=51